Eyas Medical Imaging announces the first installation of the Ascent3T™ neonatal MRI system at Cincinnati Children’s Hospital Medical Center’s neonatal intensive care unit (NICU).

While the U.S. FDA hasn’t yet cleared the Ascent3T for commercial use, Eyas has selected Cincinnati Children’s to conduct research studies involving the Ascent3T Neonatal MRI System. Eyas hopes to apply to the FDA for 510(k) clearance soon, company officials reveal

The Ascent3T utilizes a 3 Tesla (3T) magnet, providing a magnetic field strength previously unavailable in neonatal MRI systems, Eyas officials say. A 3T magnet enables a more comprehensive and precise diagnostic tool, providing healthcare professionals with detailed imaging of vital organs, including the brain, lungs, heart, and abdomen. 

Moreover, the Ascent3T  MRI system is a compact and specially engineered device that eliminates the need to transport delicate newborns to other MRI locations, company officails say. The neonatal imaging device, developed by Charles Dumoulin, PhD, a professor of pediatrics and radiology at Cincinnati Children’s and founder/CTO of Eyas, is considered a breakthrough in the field. 

“The Ascent3T brings an unprecedented level of MR imaging and access to our smallest patients,” Dumoulin says. “By reinventing MRI technology, doctors can now visualize and understand neonatal health conditions using state-of-the-art MR imaging tailored to infants.”

Abram Gordon, who serves as vice president of Cincinnati Children’s Innovation Ventures, which focuses on technology transfer and commercialization, adds: “This is a significant technological advancement for our most vulnerable patients and validates the high level of innovation and problem-solving happening right here in Cincinnati. This new MRI solution is a direct output from Cincinnati Children’s and further evidence of the incredible people and ideas generated here in our region.”